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http:WHAT THIS PAPER ADDS
Using the comprehensive national health care registers, we have identiﬁed all persons who were treated with
hypoglycaemic medication in Finland during 1997e2007. These data were further linked to the National Hospital
Discharge Register to identify all lower extremity amputations among the diabetic population. We evaluated
several indicators that can be used for controlling the outcomes of treatment to prevent amputations and fatal
outcome after a minor amputation. We were also able to make regional benchmarking and follow time trends
with amputations. The study is unique, because of a long follow-up period of all diabetic persons in one country,
and also because we were able to recommend indicators for international comparisons.Objective: To test various indicators for comparing the outcomes of diabetic foot care.
Design: All 396,317 patients treated with hypoglycaemic medication in Finland were followed up based on
nationwide registers on hospital discharges and causes of death during 1997e2007.
Materials and methods: The crude and standardized incidences of lower extremity amputations (LEAs), the
minoremajor ratio of the ﬁrst LEA and 2-year survival with a preserved leg after the ﬁrst minor LEA were used as
indicators for regional and temporal variation in diabetic foot care.
Results: A total of 13,469 LEAs were recorded in 1997e2007. The standardized population-corrected rate of ﬁrst
major LEA per 100,000 person-years declined from 10.0 (95% CI 9.6e10.5) to 7.3 (6.9e7.6) (p < .001), while the
minoremajor LEA ratio progressed from 0.86 (0.80e0.92) to 1.35 (1.26e1.46) (p < .001). By using these
indicators, variation was observed between the university hospital catchment areas. Nationwide, the 2-year
survival with a preserved leg after the ﬁrst minor LEA increased statistically insigniﬁcantly from 50.8% (47.3e
54.6%) to 55.4% (51.9e59.0%) (p ¼ .08).
Conclusions: The standardized, population-corrected incidence of major LEA, the minoremajor LEA ratio, and
major-amputation-free survival proved useful as indicators in comparing the outcomes of diabetic foot care.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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such as coronary heart disease, stroke, and peripheral
vascular disease. More could be done to avoid or postpone
these complications. Global variation in the incidence of
lower extremity amputation (LEA) ranges from 46.1 to 9,600
and in the incidence of major (through or proximal to the
ankle joint) LEAs from 5.6 to 600 per 100,000 person-years in
the diabetic population.1 The risk of LEA was more than 20
times higher among diabetic patients than in non-diabeticTo access continuing medical education questions on this pa-
ase go to www.vasculareducation.com and click on ‘CME’
rresponding author. K. Winell, National Institute for Health and
e, PO Box 30, FI-00271 Helsinki, Finland.
il address: klas.winell@conmedic.ﬁ (K. Winell).
-5884/$ e see front matter  2013 European Society for Vascular
. Published by Elsevier Ltd. All rights reserved.
//dx.doi.org/10.1016/j.ejvs.2013.07.010patients in the total population of England.2 We found a
sevenfold risk for a major amputation in the Finnish diabetic
population compared with the non-diabetic population.3
Several studies have investigated temporal changes in
amputation incidences. In England, no statistically signiﬁ-
cant changes had taken place in the risk of minor (distal to
ankle joint) or major LEA among persons with diabetes from
2004 to 2008.2 In Spain, both minor and major LEA in-
cidences decreased signiﬁcantly among persons with type 1
diabetes and increased signiﬁcantly among persons with
type 2 diabetes from 2001 to 2008.4 Research on post-
amputation mortality is scarce.5
The quality, effectiveness and safety of treatments should
be measured with indicators that cover the patient’s
capability for physical activity and survival. The lack of a
clear consensus on valid indicators may obscure compari-
sons in diabetic foot care.6 In the current study, we aimed at
studying several outcome indicators for evaluating the
570 K. Winell et al.effectiveness of foot care in the prevention of LEA. The
applicability of these indicators for detecting regional and
temporal variation in foot care over time was tested among
Finnish patients with diabetes.METHODS
We executed a register study utilizing the comprehensive
national registers for the period 1997e2007. Personal iden-
tity (ID) codes allowed for complete register linkages. A
diagnosis of diabetes was made if a person was on hypo-
glycaemic medication or had been hospitalized for diabetes.
The use of hypoglycaemic medication is registered in the
reimbursement register of the Social Insurance Institution;
the register mentions all appointed special reimbursement
rights for hypoglycaemic medication (data from 1964 to
2007) and medication purchases registered with the
Anatomic Therapeutic Chemical (ATC) classiﬁcation code A10
(1994e2007). The high reimbursement level for hypo-
glycaemic medication has resulted in full coverage of di-
abetics in themedication registers. Furthermore, all causes of
hospitalization are recorded in the Hospital Discharge Reg-
ister (HDR; data from 1969 to 2007) by International Classi-
ﬁcation of Diseases (ICD) code (www.who.int/classiﬁcations/
icd/en). Diabetes has been registered with ICD-8 and ICD-9
code 250 and with ICD-10 codes E10e14. The HDR is
comprehensive, as every hospital in the country is obligated
by law to report on hospital discharges. Comparison with a
local diabetes register for the Helsinki Metropolitan Area
conﬁrmed the comprehensive inclusion of all persons with
diabetes in the diabetes register created.7
Mortality was followed until 2008 based on the Causes of
Death register maintained by Statistics Finland. Those who
werenot permanent residents in the countryor had gestational
diabetes only were excluded from our analyses. A compre-
hensive description of the study population is available.8
After identifying all personswith diabetes in the country, the
datawere cross-linkedwith theHDRusing personal ID codes to
identify the patients who had undergone a LEA using Nordic
and national procedure codes (data from 1987 to 2007).9 All
LEAs through andproximal to the anklewere consideredmajor,
and those distal to the ankle were considered minor. We
excluded LEAs due to neoplasm or trauma, with the exception
of those recorded with ICD-10 codes S90e91 (superﬁcial le-
sions of foot), T80e81 (complications of therapies), and
T87.3eT87.6 (complications at amputation site).
The outcome was measured for 1997e2007 with the
following indicators: the total number of LEAs; the crude and
standardized incidences of all LEAs, all major LEAs, the ﬁrst
LEA and the ﬁrst major LEA; the minoremajor ratio of ﬁrst
LEA; and 2-year survival and 2-year survival with a preserved
leg after the ﬁrst minor LEA. All incidence indicators were
calculated by using two different denominators, for example
the diabetic population and the overall population (popula-
tion-corrected indicators). The population correction was
intended to “remedy” the confounding effect of the rapid
increase in the diabetic population on amputation trends.The
direct method for age and sex standardization (with the agegroups 0e29, 30e49, 50e64, 65e74, 75e84, and over 84
years of age) was used with the combined population of
1997e2007 as the standard population, that is crude rates
were ﬁrst computed for each stratum and the strata were
then combined to forma standardized rate using the standard
population weights. In order to compare the changes in the
trends of these indicators, we further divided the actual in-
dicator values with the baseline incidence in 1997: each in-
dicator had a value of one for the year 1997, and changes
were measured in relation to that baseline year.
Theminoremajor LEA ratiowith conﬁdence interval (CI)was
calculated as a rate ratio. Because the same denominator was
used for minor and major LEAs, the denominators were
cancelled out and the same ratio was obtained directly from
the ratio of absolute numbers ofminor andmajor amputations.
The 2-year survival and 2-year survival with a preserved
leg were calculated using the KaplaneMeier method. The
observation was considered censored on the ﬁnal day of
2008 if no event of interest had occurred by then.
Regional comparisons were performed with standardized,
population-corrected rates between the ﬁve university hos-
pital districts including their secondary catchment areas.
Temporal comparisons for each region were drawn between
the periods of 1997e2000 and 2004e2007. For all indicators,
uncertainty was presented in terms of conﬁdence intervals,
and statistical testing was performed using the Wald and
likelihood ratio tests with the Poisson regression model.
All statistical analyses were performed with R software
using the Survo R package (www.survo.ﬁ/muste). The study
was approved by the ethical committee of the National
Institute for Health and Welfare.
RESULTS
Among Finnish patients with diabetes, the annual number
of ﬁrst major amputations decreased from 477 to 424 be-
tween 1997 and 2007; the corresponding ﬁgures for all
major amputations were 637 and 542, respectively. Because
of an increase in the number of minor amputations, the
annual number of ﬁrst LEAs increased from 692 to 786 and
of all LEAs from 1,157 to 1,298 over the same period.
The crude and standardized rates of all major LEAs and ﬁrst
major LEAsweremarkedly lower towards the end of the study
period (Fig. 1). The standardized, population-corrected rates
for all LEAs, ﬁrst LEAs, all major LEAs, and ﬁrst major LEAs
decreased during the study period (Table 1 and Fig. 1). The
decrease was more prominent when the diabetic population
was used as a risk population, but also remained marked
when the whole population was considered to represent the
risk population (i.e. with population-corrected values)
(Fig. 1). The standardized, population-corrected rates of all
major LEAs and ﬁrst major LEAs for persons with diabetes
declined signiﬁcantly during the study period (Table 1).Comparing university hospital catchment areas
The standardized, population-corrected rate of ﬁrst major
LEAs declined signiﬁcantly in all university hospital catch-
ment areas from the observation period 1997e2000 to that
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Figure 1. The crude and standardized incidences of all amputations, all major amputations, ﬁrst amputations and ﬁrst major amputations in
the diabetic population and in the whole population of Finland from 1997 to 2007. The year 1997 is given a value of one (¼1).
PC ¼ population-corrected.
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the rate and pace of change between the regions. The stan-
dardized, population-corrected rate of ﬁrst LEAs showed
regional variation but had a signiﬁcant decrease in only two
of the regions (Fig. 2).Table 1. Standardized, population-corrected rates (SR) of all diabetic low
and ﬁrst major LEAs per 100,000 inhabitants (with 95% CI) from 1997
Year SR of all
LEAs
95% CI SR of
the ﬁrst
LEA
9
1997 24.6 23.2e26.0 14.7 1
1998 24.6 23.2e26.0 14.7 1
1999 26.3 24.9e27.8 15.3 1
2000 25.0 23.6e26.4 14.9 1
2001 25.3 23.9e26.6 14.3 1
2002 24.1 22.8e25.4 14.1 1
2003 22.9 21.6e24.1 13.2 1
2004 21.4 20.1e22.6 12.7 1
2005 21.2 20.0e22.4 12.2 1
2006 21.6 20.4e22.8 13.0 1
2007 22.5 21.3e23.7 13.5 1
p Value for linear trend <0.001 <0.001The minoremajor ratio of ﬁrst LEAs increased signiﬁ-
cantly in the entire country e from 0.86 (95% CI 0.80e0.92)
to 1.35 (1.26e1.46), p < .001. It also increased in all ﬁve
university hospital catchment areas. The increase was sig-
niﬁcant in all but one of the regions (Fig. 2). We founder extremity amputations (LEAs), ﬁrst diabetic LEAs, all major LEAs
to 2007 in Finland; the whole population as a risk population.
5% CI SR of all
major
LEAs
95% CI SR of
the ﬁrst
major LEA
95% CI
3.6e15.8 13.6 12.5e14.6 10.2 9.2e11.1
3.6e15.8 13.2 12.2e14.3 10.1 9.2e11.0
4.2e16.4 13.9 12.8e14.9 10.2 9.3e11.1
3.8e15.9 13.0 12.0e14.0 9.6 8.8e10.5
3.2e15.3 12.3 11.3e13.2 9.3 8.5e10.1
3.1e15.2 11.7 10.8e12.6 9.0 8.2e9.8
2.2e14.2 10.5 9.6e11.4 7.5 6.8e8.3
1.7e13.6 9.5 8.6e10.3 7.3 6.6e8.0
1.3e13.1 9.9 9.1e10.8 7.5 6.8e8.2
2.0e13.9 8.9 8.1e9.6 6.9 6.2e7.6
2.6e14.5 9.3 8.6e10.1 7.3 6.6e8.0
<0.001 <0.001
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Figure 2. Comparison of the standardized, population-corrected (the whole population as risk population) rates of the ﬁrst amputation
(LEA) and ﬁrst major LEA as well as the minoremajor amputation ratio of ﬁrst LEAs in the ﬁve Finnish university hospital districts including
their secondary catchment areas during the periods 1997e2000 (upper line for each catchment area in red) and 2004e2007 (lower line for
each catchment area in blue). If conﬁdence intervals do not overlap, the difference is statistically signiﬁcant.
572 K. Winell et al.statistically signiﬁcant differences in the minoremajor ra-
tios between the university hospital catchment areas for
the earlier observation period, but not for the later obser-
vation period.Survival
There were no signiﬁcant changes in 2-year survival after the
ﬁrst minor LEA from the period 1997e2000 to the period
2004e2007 (Table 2). The 2-year survival with a preserved
leg after the ﬁrst minor LEA increased from 50.8% (95% CI
47.3e54.6%) to 55.4% (95% CI 51.9e59.0%) in the whole
country (Table 2). This change was also not statistically sig-
niﬁcant (p ¼ .08). Furthermore, we did not ﬁnd any statis-
tically signiﬁcant differences between the university hospital
catchment areas when studying those who survived for 2
years with a preserved leg after a minor LEA (Table 2).
DISCUSSION
A positive change over time was reﬂected by various in-
dicators that were tested to evaluate the outcome ofTable 2. The standardized, population-corrected 2-year survival rates an
minor amputation in all university hospital catchment areas and the w
Period University hospital
catchment area
2-year
survival
1997e2000 Helsinki 64.7
2004e2007 Helsinki 65.0
1997e2000 Turku 65.4
2004e2007 Turku 68.8
1997e2000 Tampere 66.2
2004e2007 Tampere 66.4
1997e2000 Kuopio 63.0
2004e2007 Kuopio 65.5
1997e2000 Oulu 62.3
2004e2007 Oulu 60.5
1997e2000 Finland 64.5
2004e2007 Finland 65.4diabetic foot care in Finland. We found a signiﬁcant
decrease in the standardized, population-corrected rates of
all LEAs, ﬁrst LEAs, all major LEAs, and ﬁrst major LEAs, in
addition to a signiﬁcant increase in the minoremajor ratio
of ﬁrst LEAs during 1997e2007. We were also able to
demonstrate that some of these indicators were more
sensitive than others in revealing regional differences. In
our material, the standardized, population-corrected rates
of major LEAs or ﬁrst major LEAs showed signiﬁcant dif-
ferences between the ﬁve Finnish university hospital
catchment areas as well as signiﬁcant improvement within
all of the ﬁve catchment areas, each covering a population
of approximately 1 million. Similarly, regional and temporal
differences were manifested by using the minoremajor
ratio as an indicator of foot care quality. The incidence of
any LEA is a commonly applied quality indicator in diabetic
foot care, but in our study it was less sensitive at detecting
temporal or regional change than were the indicators of
major LEAs. The incidence of any LEA has its shortcomings
as an indicator, because it does not identify those with
several LEAs, nor does it distinguish the patients with limbd the survival rates with a preserved leg (with 95% CI) after the ﬁrst
hole of Finland during the periods 1997e2000 and 2004e2007.
95% CI 2-year survival
with a preserved
leg
95% CI
57.3e72.7 53.8 47.1e61.2
57.9e72.7 59.0 52.4e66.3
54.6e77.7 48.9 39.5e59.7
59.0e79.6 57.5 48.7e67.5
58.1e75.1 50.4 43.4e58.4
58.6e75.0 54.9 47.8e62.7
54.3e72.7 50.9 43.1e59.8
57.5e74.2 54.0 46.8e62.1
51.7e74.5 46.7 37.5e57.5
51.1e71.1 48.4 40.0e58.1
60.5e68.7 50.8 47.3e54.6
61.6e69.3 55.4 51.9e59.0
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as an alternative to major LEA.
The level of LEA has a major inﬂuence on the patient’s
capacity to lead an active life. A minor amputation usually
does not hinder self-sufﬁciency, while a major LEA, espe-
cially one performed above the knee, may threaten it
signiﬁcantly. The goal is, therefore, to salvage as much as
possible of the lower extremity, with subsequent foot care
and active vascular treatment aiming at revascularization
when feasible. The advantages of avoiding major LEAs make
a strong argument for using the incidence of major LEAs as
an indicator for evaluating the quality of diabetic foot care.
It provides an outcome indicator for the comprehensive
chain of services from the prevention of foot problems to
cardiovascular risk management and vascular surgical care.
The minoremajor LEA ratio has been suggested to be
used as a quality indicator for foot care, and it is our
conclusion that the minoremajor ratio of the ﬁrst LEA is a
particularly useful indicator.10 The major advantage of the
minoremajor ratio is that, since the denominators are
cancelled out in the calculations, there are fewer problems
related to standardization. However, the minoremajor ratio
has weaknesses which have to be considered. A high inci-
dence of minor amputations can result from either inade-
quate initial foot care or high vascular surgical activity for
limb salvage. The activity of local surgical practices con-
cerning toe amputations may also vary. Misinterpretations
can be avoided by combining this indicator with the inci-
dence of major amputations. We have also found the
application of ﬁrst occurrence to be a valid choice in
measuring other outcomes of diabetic care, such as acute
coronary syndromes and strokes.11,12 We recommend using
the incidence of ﬁrst major LEAs and the minoremajor ratio
of ﬁrst LEAs as indicators whenever information on the
number of events is available. As suggested by the present
study, both the incidence of all major LEAs and that of ﬁrst
major LEAs yield coherent results.
Mortality is a strong indicator formeasuring theoutcomeof
care. Survival and amputation-free survival have been used as
outcome indicators after bypass surgery in critical leg
ischaemia.13e15 Indicators looking at 2-year survival or 2-year
survival with a preserved leg after the ﬁrstminor LEAwere the
only indicators tested in our study that failed to show statis-
tically signiﬁcant changesover time. However,we suggest that
the almost 5 percentage point change in the 2-year survival
with a preserved leg is clinically relevant. More studies are
needed to test whether a more sensitive indicator can be
found to detect survival trends in ischaemic foot problems.
Differences in quality measurements should always be
interpreted in the ﬁrst instance by those who are involved
in the processes of care. Some of the regional differences
between the university hospital catchment areas can
probably be explained by the pace of development in
treatment chains and options of care. In our study, for
example, changes were observed in the minoremajor ratio
of ﬁrst LEAs in all but one university hospital catchment
areas. The reason why one area did not show an improve-
ment was that the ratio was already high during the initialobservation period and, in the catchment area in question,
both minor and major LEA rates decreased during the study
period. Data on vascular procedures would have been of
assistance in interpretation. There might also have been
differences in the prevalence of diabetes and atheroscle-
rotic disease between the regions. To explain the regional
differences, a more detailed analysis should be carried out
on the revascularization activity as well as the function of
multidisciplinary diabetic foot teams and treatment chains.
Many studies have reported decreasing LEA incidences
among populations with diabetes.15e17 A few studies on
amputations have reported the crude amputation rate, but it
is well known that crude measures may show excessive dif-
ferences between regions or countries due to different
population structures.18 Age- and sex-standardizedmeasures
can be used to correct for these differences. All our analyses
of the incidences of LEA proved that the crude incidence gives
a very optimistic picture of outcomes, even after age- and sex
standardization. It is our opinion that crude incidences should
be used with caution for evaluating the quality of diabetic
foot care in light of the rapid growth of the diabetic popula-
tion due to obesity and a sedentary lifestyle as well as due to
changes in the deﬁnition of diabetes and increasing diag-
nostic activity. We have estimated previously that the in-
crease in the diabetic population may explain more than half
of the positive incidence change.3 In the current study, we
used population correction of the standardized incidence to
remedy this problem. Such correction leads to incidences
that are very small in the absolute sense as the denominator
refers to the whole population and not to the diabetic pop-
ulation, but the trends are protected against bias caused by
the rapidly increasing risk population.
The strengths of our study are that we were able to
identify all persons treated with hypoglycaemic medication
for diabetes and all LEAs performed in Finland. The long
study period and the opportunity to perform regional
comparisons provided extra value. The extensive use of
registry data allowed us to analyse several quality indicators
and compare their sensitivity in detecting differences in
amputation trends both at the national level and in com-
parisons between the university hospital catchment areas.
The weaknesses of our study include the lack of risk factor
data. Moreover, data on vascular and endovascular treat-
ments would have made our study even more informative
regarding the reasons for the regional differences.CONCLUSIONS
The problems related to the variability of amputation inci-
dence reporting and the lack of consensus on comparing
the quality of diabetic foot care inspired us to test various
indicators for temporal and regional outcome comparisons.
Among the indicators tested, the standardized, population-
corrected incidences of ﬁrst major LEAs and all major LEAs
were the most sensitive in terms of the quality of care. In
addition to the incidence data, changes in the minoremajor
ratio of ﬁrst LEAs are related to limb salvage. The survival
rates after minor LEA provide additional information about
574 K. Winell et al.the effectiveness of the entire treatment chain, although
the 2-year survival with a preserved leg was not a partic-
ularly sensitive indicator. Our results pointed out some
methodological beneﬁts and drawbacks of different in-
dicators and allowed us to propose which of these in-
dicators are the most useful for evaluating the outcome of
diabetic foot care.
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